Cargando…
Metabolic Intervention Liposome Boosted Lung Cancer Radio‐Immunotherapy via Hypoxia Amelioration and PD‐L1 Restraint
At present, radiotherapy (RT) still acquires limited success in clinical due to the lessened DNA damage under hypoxia and acquired immune tolerance owing to the amplified programmed death ligand‐1 (PD‐L1) expression. Incredibly, intracellular PD‐L1 expression depression is proven to better sensitize...
Autores principales: | Wang, Saijun, Zhou, Zaigang, Hu, Rui, Dong, Mingyue, Zhou, Xiaobo, Ren, Siyan, Zhang, Yi, Chen, Chengxun, Huang, Ruoyuan, Zhu, Man, Xie, Wanying, Han, Ling, Shen, Jianliang, Xie, Congying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288235/ https://www.ncbi.nlm.nih.gov/pubmed/37092578 http://dx.doi.org/10.1002/advs.202207608 |
Ejemplares similares
-
Selectively down-regulated PD-L1 by albumin-phenformin nanoparticles mediated mitochondrial dysfunction to stimulate tumor-specific immunological response for enhanced mild-temperature photothermal efficacy
por: Zhou, Zaigang, et al.
Publicado: (2021) -
Development and validation of an interpretable radiomic nomogram for severe radiation proctitis prediction in postoperative cervical cancer patients
por: Wei, Chaoyi, et al.
Publicado: (2023) -
CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer
por: Jin, Xiance, et al.
Publicado: (2013) -
Restraint and Non-Restraint
Publicado: (1873) -
Restraint Stress Intensifies Interstitial K(+) Accumulation during Severe Hypoxia
por: Schnell, Christian, et al.
Publicado: (2012)